22.32 USD
↘ 0.76 (3.29%)AT CLOSE (11:59 AM EDT)
Vor Biopharma Inc. Common Stock
VORNASDAQ • USD
22.66
↗ 0.34 (1.50%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
22.66
↗ 0.34 (1.50%)
Market: CLOSED
Shares of Vor Biopharma Inc. Common Stock (VOR) are trading at $22.33. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest VOR is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Sep 15, 2026.
Open?$23.06
High?$23.06
Low?$22.04
Prev. Close?$23.08
Volume?729.9K
Avg. Volume?737.0K
VWAP?$22.39
Rel. Volume?0.99x
Bid / Ask
Bid?$22.10 × 200
Ask?$23.30 × 1.0K
Spread?$1.20
Midpoint?$22.70
Valuation & Ratios
Market Cap?1.3B
Shares Out?59.2M
Float?13.2M
Float %?24.4%
P/E Ratio?2.10
P/B Ratio?-6.60
EPS?$10.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Themes
Employees
76
Market Cap
1.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-05
Address
500 BOYLSTON STREET
BOSTON, MA 02116
Phone: 617-655-6580
BOSTON, MA 02116
Phone: 617-655-6580
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.86Distress
Confidence?54%Low
Short InterestSqueeze Risk
Short % of Float?57.99%Squeeze Risk
Short Interest?7.7M
Days to Cover?10.4
Free Float13.2M
Avg Daily Volume739.5K
Settlement Date2026-08-31
Financial Health
Current Ratio?19.15Strong
Quick Ratio?19.15Strong
Cash Ratio?4.35Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?2.1CHEAP▾
Peers100
S&P97
P/B?-6.60CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-8.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-313.6%WEAK▾
S&P3
ROA?130.5%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-140813000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day